Human chorionic gonadotropin in the treatment of HIV-related Kaposi’s sarcoma

This publication has 13 references indexed in Scilit:

• The β-core fragment of human chorionic gonadotrophin inhibits growth of Kaposiʼs sarcoma-derived cells and a new immortalized Kaposiʼs sarcoma cell line
  AIDS, 1997
• Kaposi's Sarcoma -- What's Human Chorionic Gonadotropin Got to Do with It?
  New England Journal of Medicine, 1996
• The Effects of Preparations of Human Chorionic Gonadotropin on AIDS-Related Kaposi's Sarcoma
  New England Journal of Medicine, 1996
• A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter
  New England Journal of Medicine, 1996
• Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals
  The Lancet, 1996
• Quantitative Dynamics of HIV Type 1 Expression
  AIDS Research and Human Retroviruses, 1996
• Human chorionic gonadotropin for AIDS-related Kaposi's sarcoma
  The Lancet, 1995
• Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone
  Nature, 1995
• Inhibitory effect of human chorionic gonadotropin (hCG) on HIV‐1 transmission from lymphocytes to trophoblasts
  FEBS Letters, 1992
• Pulmonary Kaposi's Sarcoma: Clinical Findings and Results of Therapy
  The American Journal of Medicine, 1989